Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter defibrillators: An international multi-center study
Heart Rhythm Feb 27, 2020
Nazer B, Dale Z, Carrassa G, et al. - In this study performed in contemporary hypertrophic cardiomyopathy (HCM) subcutaneous implantable cardioverter defibrillators (S-ICD) cohort, researchers evaluated the incidence as well as the predictors of appropriate and inappropriate shock (IAS). Data were obtained from HCM patients who had S-ICD implantation at 4 centers. Etiologies of all S-ICD shocks were adjudicated. The mean follow-up was 2.7 years. There were 88 HCM patients who received S-ICD (81 for primary and 7 for secondary prevention). Taller 12-lead ECG R wave amplitude and abnormal T wave inversions were identified as independent predictors of IAS. Sudden death or untreated sustained ventricular arrhythmias did not occur in any patient. Findings of this multi-center HCM S-ICD study revealed a rare occurrence of IAS and confinement of appropriate shocks to secondary prevention patients. An increased IAS risk was conferred by R wave amplitude, and T wave inversions were identified as protective. In this cohort, over-estimation of the risk of appropriate shocks by HCM primary prevention ICD guidelines was revealed.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries